In mid-October, applications became available for the Terumo BCT 2018 Advanced Apheresis educational grant. This grant is available to a healthcare provider who treats treats patients with sickle cell disease using red blood cell exchange with peripheral vascular access.
Editor's Note: This article originally appeared on Terumo BCT's website.
"This grant is an opportunity to improve access to care and achieve better outcomes for patients with sickle cell disease. By helping healthcare providers to meet and enhance current standards of practices for peripheral vascular access, we can better support this underserved patient population." Regis Leonard, Vice President, Therapeutic Systems, Terumo BCT
Sickle cell disease is an inherited disease that can cause pain and may put patients at increased risk for infections and stroke, according to Blood, the official journal of the American Society of Hematology. The disease causes red blood cells to form an abnormal crescent shape, and it especially affects people with ancestors from Africa, India, Central and South America and the Caribbean. Click here to continue >>
News from our partners.